Joanna Renke

Joanna Renke

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2011 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
MLMagdalena Lange
Magdalena Lange
MNMarek Niedoszytko
Marek Niedoszytko
JRJoanna Renke
Joanna Renke
JGJ. Gleń
J. Gleń
Bogusław NedoszytkoBogusław Nedoszytko
Bogusław Nedoszytko

Verified
Journal Article
Open access
PDF file
MLMagdalena Lange
Magdalena Lange
KHKarin Hartmann
Karin Hartmann
MCMelody C. Carter
Melody C. Carter
FSFrank Siebenhaar
Frank Siebenhaar
IÁIván Álvarez-Twose
Iván Álvarez-Twose
Peter ValentPeter Valent
Peter Valent
Pediatric mastocytosis is a heterogeneous disease characterized by accumulation of mast cells in the skin and less frequently in other organs. Somatic or germline mutations in the KIT proto-oncogene are detected in most patients. Cutaneous mastocytosis is the most common form of the disease in children. In the majority of cases, skin lesions regress spontaneously around puberty. However, in few patients, mastocytosis is not a self-limiting disease, but persists into adulthood and can show signs of systemic involvement, especially when skin lesions are small-sized and monomorphic. Children with mastocytosis often suffer from mast cell mediator-related symptoms. Severe hypersensitivity reactions can also occur, mostly in patients with extensive skin lesions and blistering. In a substantial number of these cases, the triggering factor of anaphylaxis remains unidentified. Management of pediatric mastocytosis is mainly based on strict avoidance of triggers, treatment with H1 and H2 histamine receptor blockers, and equipment of patients and their families with epinephrine auto-injectors for use in severe anaphylactic reactions. Advanced systemic mastocytosis occurs occasionally. All children with mastocytosis require follow-up examinations. A bone marrow investigation is performed when advanced systemic mastocytosis is suspected and has an impact on therapy or when cutaneous disease persists into adulthood.

Verified
Journal Article
Open access
PDF file
WWWojciech Wołyniec
Wojciech Wołyniec
WRWojciech Ratkowski
Wojciech Ratkowski
JRJoanna Renke
Joanna Renke
MRMarcin Renke
Marcin Renke
More than 100 substances have been identified as biomarkers of acute kidney injury. These markers can help to diagnose acute kidney injury (AKI) in its early phase, when the creatinine level is not increased. The two markers most frequently studied in plasma and serum are cystatin C and neutrophil gelatinase-associated lipocalin (NGAL). The former is a marker of kidney function and the latter is a marker of kidney damage. Some other promising serum markers, such as osteopontin and netrin-1, have also been proposed and studied. The list of promising urinary markers is much longer and includes cystatin C, NGAL, kidney injury molecule-1 (KIM-1), liver-type fatty-acid-binding protein (L-FABP), interleukin 18, insulin-like growth factor binding protein 7 (IGFBP-7), tissue inhibitor of metalloproteinases-2 (TIMP-2) and many others. Although these markers are increased in urine for no longer than a few hours after nephrotoxic agent action, they are not widely used in clinical practice. Only combined IGFBP-7/TIMP-2 measurement was approved in some countries as a marker of AKI. Several studies have shown that the levels of urinary AKI biomarkers are increased after physical exercise. This systematic review focuses on studies concerning changes in new AKI biomarkers in healthy adults after single exercise. Twenty-seven papers were identified and analyzed in this review. The interpretation of results from different studies was difficult because of the variety of study groups, designs and methodology. The most convincing data concern cystatin C. There is evidence that cystatin C is a better indicator of glomerular filtration rate (GFR) in athletes after exercise than creatinine and also at rest in athletes with a lean mass lower or higher than average. Serum and plasma NGAL are increased after prolonged exercise, but the level also depends on inflammation and hypoxia; therefore, it seems that in physical exercise, it is too sensitive for AKI diagnosis. It may, however, help to diagnose subclinical kidney injury, e.g., in rhabdomyolysis. Urinary biomarkers are increased after many types of exercise. Increases in NGAL, KIM-1, cystatin-C, L-FABP and interleukin 18 are common, but the levels of most urinary AKI biomarkers decrease rapidly after exercise. The importance of this short-term increase in AKI biomarkers after exercise is doubtful. It is not clear if it is a sign of mild kidney injury or physiological metabolic adaptation to exercise.

1 July 2000 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JRJoanna Renke
Joanna Renke
SPStefan Popadiuk
Stefan Popadiuk
MKMaria Korzon
Maria Korzon
BBBożena Bugajczyk
Bożena Bugajczyk
Michał WoźniakMichał Woźniak
Michał Woźniak

1 August 2011 in Experimental Hematology
Verified
Journal Article
Closed access
BWBartosz Wasag
Bartosz Wasag
MNMarek Niedoszytko
Marek Niedoszytko
APAnna Piskorz
Anna Piskorz
MLMagdalena Lange
Magdalena Lange
JRJoanna Renke
Joanna Renke
JLJanusz Limon
Janusz Limon

1 January 2017 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
Bogusław NedoszytkoBogusław Nedoszytko
Bogusław Nedoszytko
MLMagdalena Lange
Magdalena Lange
MSMalgorzata Sokolowska-Wojdylo
Malgorzata Sokolowska-Wojdylo
JRJoanna Renke
Joanna Renke
Piotr TrzonkowskiPiotr Trzonkowski
Piotr Trzonkowski
Roman J. NowickiRoman J. Nowicki
Roman J. Nowicki
Regulatory FOXP3+ T cells (Tregs) constitute 5% to 10% of T cells in the normal human skin. They play an important role in the induction and maintenance of immunological tolerance. The suppressive effects of these cells are exerted by various mechanisms including the direct cytotoxic effect,...